The leaderless bacteriocin Garvicin KS (GarKS) is a potent antimicrobial, being active against a 21 wide range of important pathogens. GarKS production by the native producer Lactococcus 22 garvieae KS1546 was however relatively low (80 BU/ml) under standard laboratory growth 23 conditions (batch culture in GM17 at 30°C). To improve the production of GarKS, we 24 systematically evaluated the impact of different media and media components on bacteriocin 25 production. Based on the outcomes a new medium formulation was made to greatly improve 26 bacteriocin production. The new medium composed of pasteurized milk and tryptone (PM-T),
Introduction 4 times more than the production without increased gene dose (native KS1546 in PM-T), and about 147 250-fold more than that initially obtained in GM17 (native KS1546 in GM17) (Table 1) . 148 To compare the growth patterns, the native and recombinant producers were grown under similar 149 growth conditions. The recombinant producer KS1546-pA2T showed a prolonged lag growth 150 phase compared to the native GarKS producer (with or without empty plasmid). Nevertheless, 151 KS1546-pA2T reached eventually about the same high cell density as the wild type control cells 152 when it entered stationary growth phase (see Fig.4 ).
154
Optimization of culture conditions in a bioreactor increased GarKS production 155 The initial pH at 7 was declined to 4.8 when the recombinant producer KS1546-pA2T was grown 156 in PM-T for 6-7 h at 30°C (data not shown). To examine whether pH reduction could have a 157 negative impact on bacteriocin production, we grew the recombinant producer (KS1546-pA2T) in 158 PM-T in a bioreactor with constant pH at 5, 6 or 7. Indeed, pH had a great impact on cell growth 159 and bacteriocin production. Highest cell growth (0.7 ×10 10 CFU/ml) and bacteriocin production 160 (82,000 BU/ml) were found at constant pH 6 ( Table 1) . Bacteriocin production measured at all 161 time-points was also highest at constant pH 6 ( Fig. 5 ). Cell growth and bacteriocin production 162 were lowest at constant pH 5.
163
Aeration is defined as dissolved oxygen (DO) percentage in a culture medium. We observed that 164 the initial DO level at 50-60% was declined to 10% after 2 hours of cell growth in PM-T medium 165 and at constant pH 6. The effect of aeration on GarKS production was therefore examined by 166 purging the atmospheric sterile air into the growth medium (constant pH at 6). With aeration kept 167 at 50-60%, highest cell growth (1×10 10 CFU/ml) and bacteriocin production (164,000 BU/ml) were obtained (Table 1 and Fig. 5 ). This level of bacteriocin production (164,000 BU/ml) was 169 about 2000-fold more than the initial production in GM17 which was 80 BU/ml. 170 We have previously shown that synthetic GarKS is functionally comparable to the biologically 171 produced counterpart (31). Synthetic GarKS (with > 90% purity) has a specific activity of 130-172 140 BU/µg. Hence, the production of 164,000 BU/ml is equivalent to 1.2 g GarKS per liter which 173 is a level of commercial importance.
GarKS is potent against a set of important pathogens including Staphylococcus, Bacillus, Listeria, from food to medicine. Unfortunately, as also for many other bacteriocins, GarKS is produced at 179 relatively low levels during normal laboratory growth conditions (31). The low production by the 180 native producer can dramatically hamper potential applications of GarKS as industrial use of 181 bacteriocins requires high and cost-effective production. We have shown that optimization of 182 bacteriocin production by a bacterial strain is multi-factorial process, which involves the 183 systematic evaluation of nutritional ingredients and growth conditions e.g., temperature, pH and 184 aeration. The type of growth medium is probably one of the key factors in bacteriocins production 185 (33). The complex media e.g., GM17, MRS, BHI, and TH have been used in cultivation of LAB 186 because they give relatively good cell growth in laboratory conditions but not necessary for 187 bacteriocin production (34). This is illustrated in our study, GarKS production was the best in MRS 188 (320 BU/ml) but the lowest in BHI and TH (both 20 BU/ml) while the cell growth appeared about 189 in the same range in these media (1-2×10 9 CFU/ml).
190
To choose the optimal medium for bacteriocin production is often an empirical matter. The 191 components from complex media influencing bacteriocin production are often elusive and the 192 outcomes might vary significantly dependent on the type of producers. Nevertheless, some media 193 components have been shown to enhance bacteriocin production by inducing stress conditions due 194 to nutrient limitation (35) or stabilizing the bacteriocin molecules (36). The use of commercial 195 complex media (e.g., MRS) is not a cost-effective approach for large-scale bacteriocin production.
196
For instance, culture medium could account for up to 30% of the total production cost in 197 commercial biomolecule production (37). Accordingly, high costs of complex media will reduce attractiveness of bacteriocins for commercial application. Our bacteriocin producer is a strain of than in the complex media GM17, the production was 8 times less than in PM-T. Thus, further 245 studies are necessary to optimize a PM-CH-based medium in order to achieve high level and cost-246 effective bacteriocin production.
247
Low bacteriocin production is often a bottle-neck in large-scaled production of bacteriocins for 248 commercial use. Optimization of bacteriocin production is therefore an important research field to 249 better exploit the antimicrobial potential of bacteriocins, especially with regard to the decreasing 250 effects of antibiotics in infection treatments due to the global emergence of antibiotic resistance.
251
In the present study we have shown that we managed to achieve a very high level of GarKS 252 production, amounting to 164,000 BU/ml, by combining medium optimization, genetic 253 engineering and culture condition optimization. This amount is about 2,000 times higher compared 254 to the initial production in GM17 (80 BU/ml). A production of 164,000 BU/ml is equivalent to 1.2 255 g GarKS per liter. To our knowledge, this is one of the highest bacteriocin production achieved so 256 far. In comparison, nisin production has been reported to 0.40-0.80 g/L by L. lactis grown in a 257 medium composed of equal volume of skim milk and complex media GM17 (5). Finally, our study 258 and others' have shown that optimization of bacteriocin production is an empirical and multi-259 factorial process and that it is highly strain-dependent. Only by systematic evaluation of different 260 aspects influencing growth and gene regulation one can find conditions suitable for high levels of 261 production.
Bacterial strains and growth conditions
supernatants. Bacteriocin activity was quantified using a microtiter plate assay as previously 
